Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23896100 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: Placebo;   Biological: Provenge

Indicates status has not been verified in more than two years